Package 0054-0481-13

{"route": ["ORAL"], "spl_id": "7558b1b9-ed53-4abc-8a08-194c945bb00f", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0300540480134", "0300540497132", "0300540481131", "0300540482138"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845515", "998189", "1119400"], "spl_set_id": ["5aaf2fb7-93f6-40d6-941a-9583a3794ce7"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0054-0481-13)", "package_ndc": "0054-0481-13", "marketing_start_date": "20210212"}], "brand_name": "Everolimus", "product_id": "0054-0481_7558b1b9-ed53-4abc-8a08-194c945bb00f", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "0054-0481", "generic_name": "Everolimus", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "5 mg/1"}], "application_number": "ANDA207486", "marketing_category": "ANDA", "marketing_start_date": "20200608", "listing_expiration_date": "20261231"}